Spring Newsletter

We have increased the total project value that we can now support, with a matched 50% grant (total direct project costs of £30k can now be supported up to £15k).

The COVID-19 crisis, which has spread everywhere within the last weeks, highlights the vulnerability of a globalized society which has commoditized almost every essential good, regardless where it is produced and by whom.

At ILC Therapeutics Ltd we have developed molecules that regulate inflammatory responses and the complex interaction between the Innate and Adaptive Immune systems.

On a straw poll of members we found some surprising information. Given that packaging and delivering food are classified as essential activities, many of our members are working flat out.

The solutions that we have been building over the years have leveraged secure cloud services, online collaboration tools and cross-channel digital messaging. Exactly the tools that we have all been forced to adopt to support remote working whilst we all practise social distancing.

The current pandemic may cause companies to think about whether they need to consider intellectual property (IP), or whether they should prioritise their commercial situation as well as research and development into new areas.

The biotechnology industry is centrally placed in being able to tackle the spread and containment of the current coronavirus.

Recognising the wealth of professional engineering expertise held by members of the Institution of Chemical Engineers (IChemE) in critical sectors.

Many of us working in technology led businesses are naturally biased towards seeking out and designing solutions for technical challenges.

Although it seems a lifetime ago and a world away, it has only been three months since IBioIC’s 6th Annual Conference took place on 5th and 6th February.

IBioIC has welcomed three new members of staff to the team.

On February 25th BBIA held its annual conference in London, just before the panic over the coronavirus began to grip.

IChemE launched their BioFutures careers brochure at the Frank Morton careers fair on 17 February 2020.

Moving from a large company to an SME, and from pharma to food, has been a real learning curve for me.

For the majority of companies working in the bioeconomy sector, it is likely that patent protection will be instrumental in securing this investment.

The Biorefinery Glas project led by Institute of Technology, Tralee in Ireland is currently demonstrating how grass biorefinery can provide sustainable bioeconomy diversification opportunities for farmers in Ireland and across Europe.